The effect of deinsuring chlorpropamide on the prescribing of oral antihyperglycemics for Nova Scotia seniors' pharmacare beneficiaries

Pharmacotherapy

Volumn 24, Issue 6, 2004, Pages 784-791

  Sketris, Ingrid S ^a   Kephart, George C ^a,c   Frail, Dawn M ^d   Skedgel, Chris ^c   Allen, Michael J ^b  

^a DALHOUSIE UNIVERSITY   (Canada)

^b DALHOUSIE UNIVERSITY   (Canada)

^c Clinical Research Centre   (Canada)

^d Nova Scotia Department of Health   (Canada)

Author keywords

Antihyperglycemics; Chlorpropamide; Geriatrics

Indexed keywords

ACARBOSE; CHLORPROPAMIDE; GLIBENCLAMIDE; GLICLAZIDE; HYPERGLYCEMIC AGENT; INSULIN; METFORMIN; TOLBUTAMIDE;

ARTICLE; CANADA; COHORT ANALYSIS; CONTROLLED STUDY; DIABETES MELLITUS; DRUG SCREENING; EDUCATION; ELDERLY CARE; HEALTH CARE FACILITY; HEALTH INSURANCE; HUMAN; HYPOGLYCEMIA; MAJOR CLINICAL STUDY; PATIENT SELECTION;

AGED; CHLORPROPAMIDE; COHORT STUDIES; DRUG UTILIZATION REVIEW; EDUCATION, MEDICAL, CONTINUING; FORMULARIES; GOVERNMENT PROGRAMS; HUMANS; HYPOGLYCEMIA; HYPOGLYCEMIC AGENTS; INSURANCE, PHARMACEUTICAL SERVICES; NOVA SCOTIA; RETROSPECTIVE STUDIES;

EID: 2942627170     PISSN: 02770008     EISSN: None     Source Type: Journal    
DOI: 10.1592/phco.24.8.784.36073     Document Type: Article

References (33)

1. Liu GG, Christensen DB. The continuing challenge of inappropriate prescribing in the elderly: an update of the evidence. J Am Pharm Assoc 2002;42:847-57.
2. Beers MH, Ouslander JG, Rollingher I, Reuben DB, Brooks J, Beck JC. Explicit criteria for determining inappropriate medication use in nursing home residents. Arch Intern Med 1991;151:1825-32.
3. Beers MH. Explicit criteria for determining potentially inappropriate medication use by the elderly: an update. Arch Intern Med 1997;157:1531-6.
4. Jennings PE. Oral antihyperglycemics: considerations in older patients with non-insulin-dependent diabetes mellitus. Drugs Aging 1997;10:323-31.
5. Gerich JE. Oral hypoglycemic agents. N Engl J Med 1989;321:1231-45.
6. Harrower AD. Comparative tolerability of sulphonylureas in diabetes mellitus. Drug Saf 2000;22:313-20.
7. Seltzer HS. Drug-induced hypoglycemia: a review of 1418 cases. Endocrinol Metab Clin North Am 1989;18(1):163-83.
8. Shorr RI, Ray WA, Daugherty JR, Griffen MR. Individual sulfonylureas and serious hypoglycemia in older people. J Am Geriatr Soc 1996;751-5.
9. Morningstar BA, Sketris IS, Kephart GC, Sclar DA. Trends in oral antihyperglycemic and insulin use in the Nova Scotia senior population (1993-1999). Can J Clin Pharmacol 2002;9:123-9.
10. Drug Evaluation Alliance of Nova Scotia. The Drug Evaluation Alliance of Nova Scotia addresses the use of chlorpropamide in patients with type 2 diabetes. Med News [Medical Society of Nova Scotia] 2000;December:6-7.
11. Anonymous. Addressing the use of chlorpropamide in type 2 diabetes. Pharmacists' Bull [Nova Scotia Department of Community Services. Nova Scotia Seniors' Pharmacare Program] November 9, 2000;00-13:1.
12. Anonymous. QEII formulary: II. Deletions from formulary: chlorpropamide (Diabinese). D & T decisions [Queen Elizabeth II Health Sciences Centre, Halifax, Nova Scotia] 2001;May(19):1-2.
13. Imran SA, Ur E. Therapeutic approaches to type 2 diabetes. Drugs Ther Maritime Pract 2001;24(2):7-12.
14. Greene WH. Econometric analysis, 3rd ed. Upper Saddle River, Nova Scotia: Prentice-Hall, 1997.
15. Wagner AK, Soumerai SB, Zhang F, Ross-Degnan D. Segmented regression analysis of interrupted time series studies in medication use research. J Clin Pharm Ther 2002;27: 299-309.
16. Freemantle N, Eastaugh J. Using effectiveness studies for prescribing research, part 1. J Clin Pharm Ther 2002;27:383-9.
17. Freemantle N, Eastaugh J. Using effectiveness studies for prescribing research, part 2. J Clin Pharm Ther 2002;27: 469-73.
18. Davis DA, Thomson MA, Oxman AD, Haynes RB. Changing physician performance: a systematic review of the effects of continuing medical education strategies. JAMA 1995;274: 700-5.
19. Newfoundland and Labrador Prescription Drug Program. Benefit listing. Available from http://www.gov.nf.ca/health/_scripts/trdnmsrch.asp. Accessed November 26, 2003.
20. New Brunswick Prescription Drug Program. NBPDP formulary. Available from http://www.gnb.ca/0212/pdf/NBPDPFormularySept2003english.pdf. Accessed November 26, 2003.
21. Prince Edward Island Health and Social Services. Drug cost assistance programs formulary. Available from http://www.gov.pe.ca/photos/original/drug_formulary.pdf. Accessed November 26, 2003.
22. Ontario Ministry of Health. Ontario drug benefit formulary/comparative drug index. Available from http://www. health.gov.on.ca/english/providers/program/drugs/formulary/ed38_0_bk.pdf. Accessed November 26, 2003.
23. Alberta Health and Wellness. Alberta health and wellness drug benefit list. Available from http://www.ab.bluecross.ca/dbl/pdfs/ahwdbl_full_list.pdf. Accessed November 26, 2003.
24. Regie de L'Assurance Maladie du Quebec. Liste de medicaments. Available from http://www.ramq.gouv.qc.ca/fr/professionnels/listmed/lm_tdmf.shtml. Accessed November 26, 2003.
25. The Prescription Drugs Cost Assistance Act. Specified drugs regulation. Available from http://web2.gov.mb.ca/laws/regs/pdf/p115-006.95.pdf. Accessed November 26, 2003.
26. da Silva BA, Molitch ME. Pharmacologic management of type 2 diabetes in the elderly: overview of treatment options. Formulary 2000;35:580-94.
27. Cornish B. Treatment of hyperglycemia in type 2 diabetes. Pharm Pract 2001;17(11):1-8.
28. Tessier D, Dawson K, Tetrault JP, Bravo G, Meneilly GS. Glibenclamide vs gliclazide in type 2 diabetes of the elderly Diabet Med 1994;11:974-80.
29. Meltzer S, Leiter L, Daneman K, et al. Clinical practice guidelines for the management of diabetes in Canada. Can Med Assoc J 1998;159(8 suppl):S1-29.
30. Chehade JM, Mooradian AD. A rational approach to drug therapy of type 2 diabetes mellitus. Drugs 2000;60:95-113.
31. DeFronzo RA. Pharmacologic therapy for type 2 diabetes mellitus. Ann Intern Med 1999;131:281-303.
32. Oki JC, Isley WL. Diabetes mellitus. In: DiPiro JT, Talbert RL, Yee GC, Matzke GR, Wells BG, Posey LM, eds. Pharmacotherapy: a pathophysiologic approach. Toronto: McGraw-Hill, 2002:74.
33. Koda-Kimble MA, Carlisle BA. Diabetes mellitus. In: Koda-Kimble MA, Young LY, eds. Applied therapeutics: the clinical use of drugs, 7th ed. Springhouse, PA: Lippincott Williams & Wilkins, 2001:48.